Hormonal effects of an antiestrogen, tamoxifen, in normal and oligospermic men

Fertility and Sterility
A Vermeulen, F Comhaire

Abstract

The administration of tamoxifen, 20 mg/day for 10 days, to normal males produced a moderate increase in luteinizing hormone (LH), follicle-stimulating hormone (FSH), testosterone, and estradiol levels, comparable to the effect of 150 mg of clomiphene citrate (Clomid). However, whereas Clomid produced a decrease in the LH response to LH-releasing hormone (LHRH), no such effect was seen after the administration of tamoxifen. In fact, prolonged treatment (6 weeks) with tamoxifen significantly increased the LH response to LHRL. Treatment of patients with "idiopathic" oligospermia for 6 to 9 months resulted in a significant increase in gonadotropin, testosterone, and estradiol levels. A significant increase in sperm density was observed only in subjects with oligospermia below 20 X 10(6)/ml and normal basal FSH levels. When basal FSH levels were increased or oligospermia was moderate (greater than 20 X 10(6)/ml); no effect on sperm density was seen. As sperm density increased, FSH levels decreased, suggesting an inhibin effect. Sperm motility was not improved by tamoxifen treatment. In five boys with delayed puberty, tamoxifen treatment appeared to activate the pituitary-gonadal axis and pubertal development.

Citations

Nov 1, 1988·Journal of Endocrinological Investigation·F Sciarra
Jul 1, 1993·Archives of Andrology·R Breznik, E Borko
Dec 15, 2000·International Journal of Andrology·D A Adamopoulos
Jul 29, 2003·Toxicological Sciences : an Official Journal of the Society of Toxicology·Justin E AldridgeEdward D Levin
Mar 1, 2008·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Sunil Raj ThomasMoushmi Biswas
May 2, 2018·Arab Journal of Urology·Amr El MeliegyMohamed Ahmed Abd El Salam
Jan 1, 1985·Archives of Andrology·I NociG Scarselli
Dec 1, 1981·International Journal of Andrology·H MartikainenR Vihko
Jan 1, 1983·Andrologia·Ch DannerF Maier
Mar 1, 1984·The Journal of Urology·P J Sorbie, R Perez-Marrero
Jul 20, 2007·The Cochrane Database of Systematic Reviews·P VandekerckhoveE Hughes
Feb 1, 1986·The Australian & New Zealand Journal of Obstetrics & Gynaecology·P L MatsonJ L Yovich
Sep 1, 1981·Andrologia·A I Traub, W Thompson
Apr 1, 1980·Scottish Medical Journal·J S Patterson
Feb 24, 2006·Asian Journal of Andrology·Giorgio Cavallini
Dec 12, 2012·Nature Reviews. Urology·Daniela ValentiAldo E Calogero
Jan 1, 1993·Archives of Gynecology and Obstetrics·K SterzikK Lichtenberger
Feb 2, 1995·The New England Journal of Medicine·S S Howards
Feb 1, 1992·International Journal of Andrology·W KrauseP Schramm
Jan 1, 1984·Pharmacology & Therapeutics·B J Furr, V C Jordan
Feb 1, 1981·Metabolism: Clinical and Experimental·T LinH R Nankin
Mar 1, 1988·Cancer Treatment Reviews·R J Epstein
Jan 9, 2003·The Urologic Clinics of North America·Farjaad M Siddiq, Mark Sigman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.